Efficacy of Antiviral Therapy in Reactivation Prophylaxis in Patients With Hepatitis B (HBV) Infection Treated With Different Immunosuppressive Agents

被引：0
|
作者：
Deutsch, Melanie
Manolakopoulos, Spilios
Papadopoulos, Nikolaos
Tsironi, Eftychia
Solomou, Antonia
Skondra, Maria
Giannouli, Stavroula
Theochari, Maria
Papatheodoridis, George V.
Pectasides, Dimitrios G.
Koskinas, John
机构：
来源：
GASTROENTEROLOGY | 2015年 / 148卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Mo1030
引用
收藏
页码：S1068 / S1068
页数：1
相关论文
共 50 条
  • [1] EVALUATING HEPATITIS B REACTIVATION IN PATIENTS TREATED WITH DAA (DIRECTLY ACTING ANTIVIRAL AGENTS) FOR HEPATITIS C INFECTION
    Mubarak, Abdullah
    Keng, Caleb
    Talati, Tapan
    Kakadia, Avani
    HEPATOLOGY, 2020, 72 : 557A - 558A
  • [2] The Efficacy of Lamivudine in the Treatment of Reactivation of Chronic Hepatitis B Virus Infection in Patients on immunosuppressive Therapy
    Popovic, Natasa
    Stojkovic-Svirtlih, Neda
    Simonovic-Babic, Jasmina
    Boricic, Ivan
    Tomanovic, Nada
    Mitrovic, Nikola
    Delic, Dragan
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2011, 139 (11-12) : 824 - 827
  • [3] Antiviral prophylaxis for hepatitis B virus in COVID-19 patients treated with immunosuppressive drug therapy
    Mastroianni, Antonio
    Greco, Sonia
    Chidichimo, Luciana
    Mauro, Maria Vittoria
    Urso, Filippo
    Vangeli, Valeria
    ANTIVIRAL THERAPY, 2022, 27 (01)
  • [4] Chemotherapy/immunosuppressive therapy: reactivation of hepatitis B infection
    Reactions Weekly, 2006, 1105 (1) : 2 - 2
  • [5] Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis
    Yi-Chia Su
    Pei-Chin Lin
    Hsien-Chung Yu
    Chih-Chien Wu
    European Journal of Clinical Pharmacology, 2018, 74 : 1111 - 1119
  • [6] Antiviral prophylaxis during chemotherapy or immunosuppressive drug therapy to prevent HBV reactivation in patients with resolved HBV infection: a systematic review and meta-analysis
    Su, Yi-Chia
    Lin, Pei-Chin
    Yu, Hsien-Chung
    Wu, Chih-Chien
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (09) : 1111 - 1119
  • [7] Resolved hepatitis B infection in patients receiving immunosuppressive therapy: Monitor versus prophylaxis against viral reactivation
    Elsebaey, Mohamed A.
    Elbedewy, Tamer A.
    Elashry, Heba
    Elrefaey, Waleed
    Elshweikh, Samah A.
    Elhadidy, Ahmed A.
    Shalaby, Neveen A.
    Elsokkary, Assem Mohamed
    Elashtokhy, Hossam Eldin A.
    Abo-Amer, Yousry Esam-Eldin
    Abo-Elfetoh, Ashraf Rafat
    Hassanien, Sharaf Elsayed Ali
    Fouad, Amina
    Abdellatif, Raghda Samir
    Ismail, Amro Abdelaziz Mohammed
    MEDICINE, 2022, 101 (47) : E31962
  • [8] Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
    Haitham A. Azeem
    Ashraf M. Alkabeer
    Ali Sobhy Mohammed
    Amira Ahmed Hussein
    Egyptian Liver Journal, 11
  • [9] Study of hepatitis B virus infection, reactivation among patients with chronic hepatitis C infection treated by direct antiviral agents (DAAs)
    Azeem, Haitham A.
    Alkabeer, Ashraf M.
    Mohammed, Ali Sobhy
    Hussein, Amira Ahmed
    EGYPTIAN LIVER JOURNAL, 2021, 11 (01)
  • [10] Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection
    Kawagishi, Naoki
    Suda, Goki
    Onozawa, Masahiro
    Kimura, Megumi
    Maehara, Osamu
    Ito, Jun
    Nakai, Masato
    Sho, Takuya
    Natsuizaka, Mitsuteru
    Morikawa, Kenichi
    Ogawa, Koji
    Sakamoto, Naoya
    JOURNAL OF HEPATOLOGY, 2017, 67 (05) : 1106 - 1108
12345